Thermo Fisher Scientific Company Profile (NYSE:TMO)

About Thermo Fisher Scientific (NYSE:TMO)

Thermo Fisher Scientific logoThermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables. The Analytical Instruments segment provides a range of instruments, consumables, software and services. The Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products. The Laboratory Products and Services segment offers controlled temperature technologies products, growth protection and separation products, and water and laboratory products.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Advanced Medical Equipment & Technology - NEC
  • Sub-Industry: Life Sciences Tools & Services
  • Symbol: NYSE:TMO
  • CUSIP: 88355610
  • Web:
  • Market Cap: $70.21235 billion
  • Outstanding Shares: 390,119,000
Average Prices:
  • 50 Day Moving Avg: $176.75
  • 200 Day Moving Avg: $166.35
  • 52 Week Range: $139.07 - $182.87
  • Trailing P/E Ratio: 30.12
  • Foreward P/E Ratio: 16.88
  • P/E Growth: 1.68
Sales & Book Value:
  • Annual Revenue: $19.2 billion
  • Price / Sales: 3.51
  • Book Value: $57.40 per share
  • Price / Book: 3.01
  • Annual Dividend: $0.60
  • Dividend Yield: 0.3%
  • EBIDTA: $4.81 billion
  • Net Margins: 11.80%
  • Return on Equity: 15.97%
  • Return on Assets: 7.48%
  • Debt-to-Equity Ratio: 0.68%
  • Current Ratio: 1.47%
  • Quick Ratio: 0.99%
  • Average Volume: 1.36 million shs.
  • Beta: 1.06
  • Short Ratio: 1.66

Frequently Asked Questions for Thermo Fisher Scientific (NYSE:TMO)

What is Thermo Fisher Scientific's stock symbol?

Thermo Fisher Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "TMO."

How often does Thermo Fisher Scientific pay dividends? What is the dividend yield for Thermo Fisher Scientific?

Thermo Fisher Scientific announced a quarterly dividend on Wednesday, July 12th. Shareholders of record on Friday, September 15th will be given a dividend of $0.15 per share on Monday, October 16th. This represents a $0.60 annualized dividend and a yield of 0.35%. The ex-dividend date of this dividend is Thursday, September 14th. View Thermo Fisher Scientific's Dividend History.

How were Thermo Fisher Scientific's earnings last quarter?

Thermo Fisher Scientific Inc (NYSE:TMO) announced its quarterly earnings data on Wednesday, July, 26th. The company reported $2.30 EPS for the quarter, beating the consensus estimate of $2.27 by $0.03. The business earned $5 billion during the quarter, compared to analyst estimates of $4.92 billion. Thermo Fisher Scientific had a net margin of 11.80% and a return on equity of 15.97%. The business's quarterly revenue was up 10.2% compared to the same quarter last year. During the same period last year, the business posted $2.03 earnings per share. View Thermo Fisher Scientific's Earnings History.

When will Thermo Fisher Scientific make its next earnings announcement?

Thermo Fisher Scientific is scheduled to release their next quarterly earnings announcement on Thursday, October, 26th 2017. View Earnings Estimates for Thermo Fisher Scientific.

Where is Thermo Fisher Scientific's stock going? Where will Thermo Fisher Scientific's stock price be in 2017?

15 equities research analysts have issued 1 year price targets for Thermo Fisher Scientific's shares. Their predictions range from $162.00 to $210.00. On average, they expect Thermo Fisher Scientific's share price to reach $188.86 in the next year. View Analyst Ratings for Thermo Fisher Scientific.

What are analysts saying about Thermo Fisher Scientific stock?

Here are some recent quotes from research analysts about Thermo Fisher Scientific stock:

  • 1. According to Zacks Investment Research, "Thermo Fisher ended the second quarter on a promising note with both adjusted earnings and revenues beating the Zacks Consensus Estimate. We are particularly upbeat about the company gaining entry into the CDMO market through the agreement to acquire Patheon for $7.2 billion. We are also encouraged by the company’s series of product launches along with major progress in precision medicine initiatives. Thermo Fisher’s acquisition of FEI Company has already started to boost its analytical instruments portfolio. The company also opened Center of Excellence for electron microscopy in Saudi Arabia. This bullish trend has been reflected in the company’s share price performance too. Over the last three months, Thermo Fisher is trading above the broader industry. The raised 2017 guidance is all the more encouraging indicating the fact that this overall bullish trend will continue through the year." (8/1/2017)
  • 2. Evercore ISI analysts commented, "When all is said in done we will remember 4Q as being generally uneventful, with guidance coming in better than feared as investors had become concerned re the impact from slowing biopharma demand (didn't really occur), mixed A&G trends and an incremental headwind from Fx. The level of consistency we see from TMO is unusual in this challenging healthcare environment and likely helps to justify valuation that is certainly not inexpensive on an EV / EBITDA basis (particularly in a rising rate world). That being said with so few places to hide in a difficult healthcare tape, we would expect TMO's superior EPS growth to help shares to remain a preferred equity, particularly given its status as a visible compounder. Thus despite today's sharp move in shares (up a bit more than we would have anticipated) we reiterate our Buy rating as risk / reward continues to be asymmetrically biased upward." (1/31/2017)

Are investors shorting Thermo Fisher Scientific?

Thermo Fisher Scientific saw a increase in short interest in July. As of July 14th, there was short interest totalling 3,746,211 shares, an increase of 77.8% from the June 30th total of 2,107,353 shares. Based on an average daily trading volume, of 1,328,438 shares, the short-interest ratio is presently 2.8 days. Approximately 1.0% of the company's stock are short sold.

Who are some of Thermo Fisher Scientific's key competitors?

Who are Thermo Fisher Scientific's key executives?

Thermo Fisher Scientific's management team includes the folowing people:

  • Jim P. Manzi, Independent Chairman of the Board
  • Marc N. Casper, President, Chief Executive Officer, Director
  • Stephen Williamson, Chief Financial Officer, Senior Vice President
  • Mark P. Stevenson, Chief Operating Officer, Executive Vice President, President, Life Sciences Solutions
  • Seth H. Hoogasian, Senior Vice President, General Counsel, Secretary
  • Patrick M. Durbin, Senior Vice President, President - Specialty Diagnostics
  • Thomas W. Loewald, Senior Vice President, Chief Commercial Officer
  • Daniel P. Shine, Senior Vice President, President, Analytical Instruments
  • Peter E. Hornstra, Vice President, Chief Accounting Officer
  • Dion J. Weisler, Director

Who owns Thermo Fisher Scientific stock?

Thermo Fisher Scientific's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (6.82%), BlackRock Inc. (5.99%), Capital Research Global Investors (4.44%), State Street Corp (4.09%), Capital World Investors (3.01%) and Longview Partners Guernsey LTD (1.09%). Company insiders that own Thermo Fisher Scientific stock include Alan J Malus, C Martin Harris, Daniel P Shine, Jim P Manzi, Marc N Casper, Patrick M Durbin, Peter E Hornstra, Peter M Wilver, Scott M Sperling, Seth H Hoogasian, Stephen Williamson, Thomas W Loewald and William G Parrett. View Institutional Ownership Trends for Thermo Fisher Scientific.

Who sold Thermo Fisher Scientific stock? Who is selling Thermo Fisher Scientific stock?

Thermo Fisher Scientific's stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Standard Life Investments LTD, Winslow Capital Management LLC, TIAA CREF Investment Management LLC, Karp Capital Management Corp, Bank of New York Mellon Corp, Ameriprise Financial Inc. and Glenview Capital Management LLC. Company insiders that have sold Thermo Fisher Scientific stock in the last year include Daniel P Shine, Marc N Casper, Peter M Wilver, Seth H Hoogasian, Stephen Williamson and Thomas W Loewald. View Insider Buying and Selling for Thermo Fisher Scientific.

Who bought Thermo Fisher Scientific stock? Who is buying Thermo Fisher Scientific stock?

Thermo Fisher Scientific's stock was acquired by a variety of institutional investors in the last quarter, including Capital Research Global Investors, Janus Henderson Group PLC, Veritas Asset Management LLP, Harbour Capital Advisors LLC, Capital World Investors, Vanguard Group Inc., Koch Industries Inc. and Investec Asset Management LTD. View Insider Buying and Selling for Thermo Fisher Scientific.

How do I buy Thermo Fisher Scientific stock?

Shares of Thermo Fisher Scientific can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Thermo Fisher Scientific's stock price today?

One share of Thermo Fisher Scientific stock can currently be purchased for approximately $172.89.

MarketBeat Community Rating for Thermo Fisher Scientific (NYSE TMO)
Community Ranking:  3.5 out of 5 (   )
Outperform Votes:  452 (Vote Outperform)
Underperform Votes:  199 (Vote Underperform)
Total Votes:  651
MarketBeat's community ratings are surveys of what our community members think about Thermo Fisher Scientific and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Thermo Fisher Scientific (NYSE:TMO) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Hold Rating, 13 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $188.86 (9.24% upside)

Analysts' Ratings History for Thermo Fisher Scientific (NYSE:TMO)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/21/2017Bank of America CorporationReiterated RatingBuy$200.00 -> $210.00LowView Rating Details
7/20/2017Cleveland ResearchUpgradeNeutral -> BuyLowView Rating Details
7/17/2017Barclays PLCReiterated RatingOverweight$190.00 -> $200.00LowView Rating Details
7/13/2017Wells Fargo & CompanyReiterated RatingOutperform$195.00 -> $200.00LowView Rating Details
7/10/2017Citigroup Inc.Reiterated RatingBuy$182.00 -> $201.00LowView Rating Details
6/10/2017Deutsche Bank AGSet Price TargetBuy$200.00LowView Rating Details
5/18/2017Cantor FitzgeraldInitiated CoverageOverweight -> Overweight$194.00LowView Rating Details
5/17/2017Jefferies Group LLCReiterated RatingHold$175.00LowView Rating Details
4/29/2017Cowen and CompanyReiterated RatingOutperform$175.00 -> $185.00LowView Rating Details
4/28/2017Morgan StanleyBoost Price TargetOverweight$186.00 -> $192.00LowView Rating Details
4/28/2017BTIG ResearchBoost Price TargetBuy$180.00 -> $190.00LowView Rating Details
4/27/2017Leerink SwannSet Price TargetBuy$187.00LowView Rating Details
1/31/2017Evercore ISIBoost Price TargetBuy$160.00 -> $162.00N/AView Rating Details
12/12/2016Goldman Sachs Group, Inc. (The)Reiterated RatingConviction-Buy -> Conviction-Buy$170.00 -> $168.00N/AView Rating Details
9/22/2016J P Morgan Chase & CoInitiated CoverageOverweight$180.00N/AView Rating Details
7/28/2016MizuhoSet Price TargetBuy$170.00 -> $175.00N/AView Rating Details
3/2/2016Topeka Capital MarketsBoost Price TargetBuy$145.00 -> $155.00N/AView Rating Details
1/29/2016Stifel NicolausLower Price Target$158.00 -> $150.00N/AView Rating Details
1/29/2016KeyCorpLower Price TargetOverweight$152.00 -> $150.00N/AView Rating Details
1/6/2016Avondale PartnersInitiated CoverageOutperform$168.00N/AView Rating Details
10/6/2015ArgusInitiated CoverageBuy$145.00N/AView Rating Details
(Data available from 8/18/2015 forward)


Earnings History for Thermo Fisher Scientific (NYSE:TMO)
Earnings by Quarter for Thermo Fisher Scientific (NYSE:TMO)
Earnings History by Quarter for Thermo Fisher Scientific (NYSE TMO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/25/2017$2.24N/AView Earnings Details
7/26/2017Q2 2017$2.27$2.30$4.92 billion$5.00 billionViewN/AView Earnings Details
4/26/2017Q1 2017$2.02$2.08$4.68 billion$4.77 billionViewN/AView Earnings Details
1/31/2017Q416$2.38$2.41$4.98 billion$4.95 billionViewN/AView Earnings Details
10/27/2016Q316$1.97$2.03$4.39 billion$4.49 billionViewListenView Earnings Details
7/28/2016Q216$2.01$2.03$4.50 billion$4.54 billionViewListenView Earnings Details
4/28/2016Q116$1.74$1.80$4.11 billion$4.29 billionViewListenView Earnings Details
1/28/2016Q415$2.11$2.12$4.55 billion$4.65 billionViewListenView Earnings Details
10/21/2015Q315$1.79$1.80$4.10 billion$4.12 billionViewListenView Earnings Details
7/22/2015Q215$1.78$1.84$4.17 billion$4.27 billionViewListenView Earnings Details
4/22/2015Q115$1.61$1.63$4.01 billion$3.92 billionViewN/AView Earnings Details
1/29/2015Q414$1.94$1.99$4.39 billion$4.49 billionViewN/AView Earnings Details
10/22/2014Q314$1.69$1.71$4.21 billion$4.17 billionViewListenView Earnings Details
7/23/2014Q214$1.62$1.72$4.25 billion$4.32 billionViewN/AView Earnings Details
4/23/2014Q114$1.40$1.53$3.74 billion$3.90 billionViewN/AView Earnings Details
1/31/2014Q413$1.38$1.43$3.31 billion$3.47 billionViewN/AView Earnings Details
10/23/2013Q313$1.28$1.30$3.18 billion$3.19 billionViewListenView Earnings Details
7/24/2013Q2 2013$1.30$1.32$3.22 billion$3.24 billionViewListenView Earnings Details
4/24/2013Q1 2013$1.29$1.37$3.17 billion$3.19 billionViewListenView Earnings Details
1/31/2013Q4 2012$1.28$1.36$3.13 billion$3.26 billionViewListenView Earnings Details
10/24/2012$1.16$1.19ViewN/AView Earnings Details
7/25/2012$1.16$1.22ViewN/AView Earnings Details
4/25/2012$1.11$1.17ViewN/AView Earnings Details
2/1/2012$1.16$1.18ViewN/AView Earnings Details
10/26/2011$1.07$1.07ViewN/AView Earnings Details
7/27/2011$0.98$0.99ViewN/AView Earnings Details
4/27/2011$0.88$0.92ViewN/AView Earnings Details
2/2/2011$0.95$1.00ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Thermo Fisher Scientific (NYSE:TMO)
2017 EPS Consensus Estimate: $9.21
2018 EPS Consensus Estimate: $10.36
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$2.02$2.16$2.07
Q2 20173$2.22$2.27$2.25
Q3 20173$2.24$2.26$2.25
Q4 20173$2.61$2.68$2.64
Q1 20182$2.30$2.31$2.31
Q2 20182$2.55$2.58$2.57
Q3 20182$2.55$2.55$2.55
Q4 20182$2.90$2.97$2.94
(Data provided by Zacks Investment Research)


Current Dividend Information for Thermo Fisher Scientific (NYSE:TMO)
Next Dividend:10/16/2017
Annual Dividend:$0.60
Dividend Yield:0.35%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:10.45% (Trailing 12 Months of Earnings)
6.49% (Based on This Year's Estimates)
5.86% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Dividend History by Quarter for Thermo Fisher Scientific (NYSE TMO)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Thermo Fisher Scientific (NYSE:TMO)
Insider Ownership Percentage: 0.49%
Institutional Ownership Percentage: 87.60%
Insider Trades by Quarter for Thermo Fisher Scientific (NYSE:TMO)
Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)
Insider Trades by Quarter for Thermo Fisher Scientific (NYSE:TMO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/5/2017Stephen WilliamsonCFOSell2,500$176.26$440,650.00View SEC Filing  
6/1/2017Marc N CasperCEOSell20,000$172.79$3,455,800.00View SEC Filing  
5/24/2017Daniel P ShineInsiderSell4,688$171.88$805,773.44View SEC Filing  
4/27/2017Thomas W LoewaldInsiderSell1,532$168.76$258,540.32View SEC Filing  
3/15/2017Marc N CasperCEOSell20,000$158.60$3,172,000.00View SEC Filing  
3/15/2017Peter M WilverVPSell9,079$160.73$1,459,267.67View SEC Filing  
3/10/2017Peter M WilverVPSell9,987$158.18$1,579,743.66View SEC Filing  
3/8/2017Thomas W LoewaldInsiderSell7,675$157.39$1,207,968.25View SEC Filing  
3/6/2017Seth H HoogasianVPSell3,142$158.71$498,666.82View SEC Filing  
3/6/2017Stephen WilliamsonCFOSell2,500$158.71$396,775.00View SEC Filing  
3/6/2017Thomas W LoewaldSVPSell4,049$158.71$642,616.79View SEC Filing  
9/2/2016Marc N CasperCEOSell28,797$151.01$4,348,634.97View SEC Filing  
9/1/2016Marc N CasperCEOSell30,000$151.17$4,535,100.00View SEC Filing  
8/29/2016Daniel P ShineSVPSell1,699$152.28$258,723.72View SEC Filing  
8/29/2016Seth H HoogasianVPSell2,270$152.28$345,675.60View SEC Filing  
8/29/2016Thomas W LoewaldInsiderSell3,256$152.28$495,823.68View SEC Filing  
8/26/2016Thomas W LoewaldInsiderSell913$151.92$138,702.96View SEC Filing  
8/10/2016Seth H HoogasianVPSell5,023$156.00$783,588.00View SEC Filing  
8/5/2016C Martin HarrisDirectorSell390$157.33$61,358.70View SEC Filing  
7/13/2016Thomas W LoewaldSVPSell8,025$155.00$1,243,875.00View SEC Filing  
7/5/2016Marc N CasperCEOSell20,000$147.69$2,953,800.00View SEC Filing  
7/1/2016Marc N CasperCEOSell30,000$148.85$4,465,500.00View SEC Filing  
6/15/2016Daniel P ShineSVPSell6,900$148.31$1,023,339.00View SEC Filing  
6/10/2016Peter M WilverVPSell68,200$152.38$10,392,316.00View SEC Filing  
6/3/2016Jim P ManziDirectorSell1,137$153.00$173,961.00View SEC Filing  
6/2/2016Thomas W LoewaldSVPSell15,000$152.84$2,292,600.00View SEC Filing  
5/16/2016Peter E HornstraCAOSell7,811$150.00$1,171,650.00View SEC Filing  
4/26/2016Daniel P ShineSVPSell6,013$146.00$877,898.00View SEC Filing  
4/5/2016Seth H HoogasianVPSell10,000$141.86$1,418,600.00View SEC Filing  
4/4/2016Patrick M DurbinSVPSell16,250$142.18$2,310,425.00View SEC Filing  
3/21/2016Stephen WilliamsonCFOSell10,708$139.50$1,493,766.00View SEC Filing  
3/14/2016Marc N CasperCEOSell30,000$139.28$4,178,400.00View SEC Filing  
3/10/2016Alan J MalusEVPSell25,925$139.05$3,604,871.25View SEC Filing  
3/9/2016Alan J MalusEVPSell15,446$138.50$2,139,271.00View SEC Filing  
3/3/2016Scott M SperlingDirectorSell5,350$137.90$737,765.00View SEC Filing  
3/3/2016Thomas W LoewaldSVPSell3,625$137.28$497,640.00View SEC Filing  
3/1/2016Seth H HoogasianVPSell2,951$135.00$398,385.00View SEC Filing  
2/1/2016Alan J. MalusEVPSell103,400$130.24$13,466,816.00View SEC Filing  
1/15/2016Daniel P. ShineSVPSell6,000$131.77$790,620.00View SEC Filing  
12/14/2015Thomas W. LoewaldSVPSell13,013$134.18$1,746,084.34View SEC Filing  
12/11/2015William G ParrettDirectorBuy1,000$134.16$134,160.00View SEC Filing  
12/7/2015Alan J. MalusEVPSell82,300$135.49$11,150,827.00View SEC Filing  
11/4/2015Seth H HoogasianVPSell1,692$135.00$228,420.00View SEC Filing  
11/3/2015C Martin HarrisDirectorSell531$134.35$71,339.85View SEC Filing  
11/2/2015Jim P. ManziDirectorSell3,050$133.49$407,144.50View SEC Filing  
9/17/2015Marc N CasperCEOSell25,000$130.00$3,250,000.00View SEC Filing  
8/28/2015Alan J MalusEVPSell4,557$127.55$581,245.35View SEC Filing  
7/14/2015Andrew J ThomsonSVPSell5,000$135.23$676,150.00View SEC Filing  
7/14/2015Peter E HornstraCAOSell7,381$136.02$1,003,963.62View SEC Filing  
6/3/2015Tyler JacksDirectorSell15,000$129.95$1,949,250.00View SEC Filing  
6/1/2015Alan J MalusEVPSell40,350$129.54$5,226,939.00View SEC Filing  
5/26/2015Thomas J LynchDirectorSell5,000$131.09$655,450.00View SEC Filing  
5/21/2015Peter M WilverCFOSell28,100$133.00$3,737,300.00View SEC Filing  
4/23/2015Thomas J LynchDirectorSell5,000$130.15$650,750.00View SEC Filing  
4/21/2015Seth H HoogasianVPSell13,256$135.00$1,789,560.00View SEC Filing  
4/13/2015Alan J MalusEVPSell11,032$133.67$1,474,647.44View SEC Filing  
4/13/2015Andrew J ThomsonSVPSell12,425$133.50$1,658,737.50View SEC Filing  
4/1/2015Marc N CasperCEOSell20,000$131.89$2,637,800.00View SEC Filing  
3/30/2015Thomas J LynchDirectorSell5,000$134.40$672,000.00View SEC Filing  
3/30/2015Thomas W LoewaldSVPSell5,307$134.40$713,260.80View SEC Filing  
3/9/2015Alan J MalusEVPSell14,479$128.11$1,854,904.69View SEC Filing  
2/23/2015Edward A PesickaSVPSell28,713$130.93$3,759,393.09View SEC Filing  
2/20/2015Peter M WilverCFOSell50,700$130.12$6,597,084.00View SEC Filing  
2/20/2015Thomas W LoewaldSVPSell15,037$127.94$1,923,833.78View SEC Filing  
2/5/2015Alan J MalusEVPSell50,000$126.83$6,341,500.00View SEC Filing  
12/18/2014Alan J MalusEVPSell11,618$125.20$1,454,573.60View SEC Filing  
11/19/2014Peter E HornstraCAOSell8,363$125.00$1,045,375.00View SEC Filing  
8/27/2014Alan J MalusEVPSell13,115$120.61$1,581,800.15View SEC Filing  
8/27/2014Seth H HoogasianVPSell10,577$120.77$1,277,384.29View SEC Filing  
8/27/2014Thomas W LoewaldSVPSell2,349$120.90$283,994.10View SEC Filing  
7/30/2014Seth H HoogasianVPSell5,103$123.82$631,853.46View SEC Filing  
7/25/2014Thomas W LoewaldSVPSell6,000$125.23$751,380.00View SEC Filing  
4/29/2014Jim ManziDirectorSell3,000$114.85$344,550.00View SEC Filing  
4/28/2014Thomas LoewaldSVPSell8,688$114.49$994,689.12View SEC Filing  
3/24/2014Edward PesickaSVPSell80,044$120.75$9,665,313.00View SEC Filing  
2/26/2014Alan MalusEVPSell7,640$124.11$948,200.40View SEC Filing  
2/14/2014Andrew ThomsonSVPSell16,725$123.14$2,059,516.50View SEC Filing  
2/10/2014Peter HornstraCAOSell9,234$117.72$1,087,026.48View SEC Filing  
2/7/2014Marc CasperCEOSell208,765$115.70$24,154,110.50View SEC Filing  
2/7/2014Peter WilverCFOSell91,897$115.21$10,587,453.37View SEC Filing  
2/6/2014Thomas LoewaldSVPSell22,437$114.24$2,563,202.88View SEC Filing  
2/6/2014William ParrettDirectorSell18,000$114.33$2,057,940.00View SEC Filing  
9/16/2013Alan MalusEVPSell4,000$91.87$367,480.00View SEC Filing  
8/15/2013Alan MalusEVPSell4,000$91.11$364,440.00View SEC Filing  
7/24/2013Edward A PesickaSVPSell80,700$91.00$7,343,700.00View SEC Filing  
6/17/2013Marc N CasperCEOSell43,396$85.58$3,713,829.68View SEC Filing  
6/17/2013Seth H HoogasianVPSell35,431$85.59$3,032,539.29View SEC Filing  
6/10/2013Judy C LewentDirectorSell15,000$85.19$1,277,850.00View SEC Filing  
6/7/2013Edward A PesickaSVPSell167,980$85.28$14,325,334.40View SEC Filing  
5/24/2013C Martin HarrisDirectorSell1,260$87.21$109,884.60View SEC Filing  
5/15/2013Alan J MalusEVPSell4,000$84.43$337,720.00View SEC Filing  
5/14/2013Scott M SperlingDirectorSell8,000$84.65$677,200.00View SEC Filing  
5/7/2013Andrew J ThomsonSVPSell12,700$83.65$1,062,355.00View SEC Filing  
5/7/2013Jim P ManziDirectorSell7,500$82.78$620,850.00View SEC Filing  
11/1/2012Marc N CasperCEOSell125,000$62.49$7,811,250.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Thermo Fisher Scientific (NYSE:TMO)
Latest Headlines for Thermo Fisher Scientific (NYSE:TMO)
DateHeadline logoAgilent shares jump 4% after earnings blow past estimates - MarketWatch - August 17 at 8:27 AM logoSee what the IHS Markit Score report has to say about Thermo Fisher Scientific Inc. - August 13 at 6:54 AM logoThermo Fisher Scientific Inc (NYSE:TMO) Receives Average Recommendation of "Buy" from Brokerages - August 12 at 12:44 AM logoBRIEF-Thermo Fisher Scientific files preliminary prospectus supplement related to a potential two-part notes offering - August 10 at 9:47 PM logoThermo Fisher Scientific, Inc. – Value Analysis (NYSE:TMO) : August 8, 2017 - August 10 at 9:47 PM logoThermo Fisher Scientific Prices Offering of Senior Notes - August 10 at 9:47 PM logoSpectrum Brands Holdings, Inc. (SPB) Ex-Dividend Date Scheduled for August 11, 2017 - Nasdaq - August 10 at 4:41 PM logoThermo Fisher Scientific (Finance I) B.V. -- Moody's assigns Baa2 to Thermo Fisher's bond offering - August 10 at 4:41 PM logoCramer: Secondary Offerings Get Primary Attention - August 10 at 8:50 AM logoCramer: Secondary Offerings Get Primary Attention - August 10 at 8:50 AM logoThermo Fisher Scientific Prices Offering of Common Stock - PR Newswire (press release) - August 9 at 8:18 AM logoThermo Fisher Scientific (TMO) Commences $1.5B Common Stock Offering - August 8 at 7:35 AM logoThermo Fisher Scientific's New Talos F200i S/TEM Delivers Flexible, High-Performance Imaging - August 8 at 7:35 AM logoThermo Fisher Scientific, Inc. breached its 50 day moving average in a Bullish Manner : TMO-US : August 7, 2017 - August 8 at 7:34 AM logo Brokerages Expect Thermo Fisher Scientific Inc (TMO) Will Post Quarterly Sales of $4.86 Billion - August 6 at 7:54 AM logoZacks: Analysts Anticipate Thermo Fisher Scientific Inc (TMO) Will Announce Earnings of $2.24 Per Share - August 4 at 4:44 PM logoEarnings Review and Free Research Report: Thermo Fisher’s Revenue Jumped 10%; EPS Climbed 20% - August 3 at 7:58 AM logoThermo Fisher Scientific Inc (NYSE:TMO) Upgraded to Buy at Zacks Investment Research - August 1 at 3:22 PM logoHead to Head Review: Edwards Lifesciences Corporation (EW) vs. Thermo Fisher Scientific (NYSE:TMO) - August 1 at 12:14 PM logoShort Interest in Thermo Fisher Scientific Inc (NYSE:TMO) Rises By 77.8% - August 1 at 7:12 AM logoThermo Fisher Scientific Completes CE-IVD Registration of its QuantStudio™ 5 Dx System for In Vitro Diagnostic Use in Europe - August 1 at 6:57 AM logoThermo Fisher Scientific Advances Innovation for the Clinic at AACC 2017 - August 1 at 6:57 AM logoWhat Analysts Recommend for Thermo Fisher Scientific - August 1 at 6:57 AM logoKey Highlights from Thermo Fisher Scientific’s 2Q17 Earnings - August 1 at 6:57 AM logoThermo Fisher Scientific Inc (NYSE:TMO) Downgraded by Zacks Investment Research - July 31 at 12:44 PM logoThermo Fisher Scientific Inc (TMO) Forecasted to Post Q3 2017 Earnings of $2.25 Per Share - July 31 at 7:03 AM logoBrokers Offer Predictions for Thermo Fisher Scientific Inc's FY2017 Earnings (TMO) - July 28 at 11:46 AM logoEarnings Reaction History: Thermo Fisher Scientific Inc., 44.4% Follow-Through Indicator, 2.7% Sensitive - Nasdaq - July 28 at 8:53 AM logoZimmer (ZBH) Tops Q2 Earnings, Drops View on Dull Sales - July 28 at 8:53 AM logoStrategy To YieldBoost Thermo Fisher Scientific From 0.3% To 4.3% Using Options - Nasdaq - July 27 at 8:27 AM logoThermo Fisher Scientific (TMO) Q2 2017 Results - Earnings Call Transcript - Seeking Alpha - July 27 at 8:26 AM logoEdited Transcript of TMO earnings conference call or presentation 26-Jul-17 12:30pm GMT - July 27 at 8:26 AM logoThermo Fisher Scientific Inc (NYSE:TMO) Posts Earnings Results, Beats Estimates By $0.04 EPS - July 26 at 12:01 PM logoThermo Fisher Scientific beats by $0.03, beats on revenue - July 26 at 9:00 AM logoShould You Buy Thermo Fisher Scientific Inc. (TMO) Ahead of Earnings? - July 26 at 9:00 AM logoThermo Fisher Scientific Reports Second Quarter 2017 Results - July 26 at 9:00 AM logoInvestor Network: Thermo Fisher Scientific Inc. to Host Earnings Call - July 26 at 9:00 AM logoThermo Fisher beats Street 2Q forecasts - July 26 at 9:00 AM logoThermo Fisher (TMO) Beats on Q2 Earnings & Sales Estimates - July 26 at 9:00 AM logoWhat Do Analysts Recommend for Thermo Fisher Scientific? - July 25 at 7:39 AM logoWhat Analysts Predict for Thermo Fisher’s 2Q17 Revenues - July 25 at 7:39 AM logoEquities Analysts Offer Predictions for Thermo Fisher Scientific Inc's Q1 2018 Earnings (TMO) - July 21 at 2:04 PM logoThermo Fisher Scientific Inc (TMO) Given Buy Rating at Bank of America Corporation - July 21 at 9:30 AM logoThermo Fisher Scientific Announces Asia Precision Medicine Research Array for ... - July 21 at 7:53 AM logoThermo Fisher Scientific Inc (NYSE:TMO) Upgraded at Cleveland Research - July 20 at 11:13 AM logoFY2017 EPS Estimates for Thermo Fisher Scientific Inc Raised by Jefferies Group (NYSE:TMO) - July 20 at 9:54 AM logoThermo Fisher Scientific Prices Offering of Euro-Denominated Senior Notes - PR Newswire (press release) - July 19 at 8:22 AM logoThermo Fisher Scientific Inc (TMO) Scheduled to Post Earnings on Wednesday - July 19 at 8:15 AM logoThermo Fisher Scientific (Finance I) B.V. -- Moody's assigns Baa2 to Thermo Fisher's EUR bonds; outlook stable - July 18 at 9:06 AM logoThermo Fisher Scientific Inc (TMO) Receives Consensus Rating of "Buy" from Brokerages - July 18 at 12:48 AM



Thermo Fisher Scientific (TMO) Chart for Friday, August, 18, 2017

This page was last updated on 8/18/2017 by Staff